Søgeord (guidelines) valgt.
10 emner vises.
1
Health Workers Fear Profits May Trump Safety in New CDC Recs
Medscape Infectious Diseases, 20.03.2024
Tilføjet 20.03.2024
As the agency develops key guidelines on infection control for hospitals, nursing homes, and other healthcare facilities, some workers feared the advice will put money above safety. KFF Health News
Læs mere
2
Epidemiology of gonorrhoea: systematic review, meta-analyses, and meta-regressions, World Health Organization European Region, 1949 to 2021
Omar Chidiac, Sawsan AlMukdad, Manale Harfouche, Emma Harding-Esch and Laith J Abu-Raddad
Eurosurveillance latest updates, 1.03.2024
Tilføjet 1.03.2024
BackgroundEpidemiology of Neisseria gonorrhoeae (NG) infection remains inadequately understood. AimWe aimed to characterise NG epidemiology in Europe. MethodsWe used Cochrane and PRISMA guidelines to systematically review, report, synthesise and analyse NG prevalence data from 1949 to 30 September 2021. Random-effects meta-analyses estimated pooled prevalence. Meta-regression analyses investigated associations and sources of heterogeneity. ResultsThe 844 included publications yielded 1,573 prevalence measures. Pooled prevalence of current urogenital infection was 1.0% (95% CI: 0.7–1.2%) among general populations, 3.2% (95% CI: 1.8–4.8%) among female sex workers, 4.9% (95% CI: 4.2–5.6%) among sexually transmitted infection clinic attendees and 12.1% (95% CI: 8.8–15.8%) among symptomatic men. Among men who have sex with men, pooled prevalence was 0.9% (95% CI: 0.5–1.4%), 5.6% (95% CI: 3.6–8.1%), and 3.8% (95% CI: 2.5–5.4%), respectively, for current urogenital, anorectal or oropharyngeal infection. Current urogenital, anorectal or oropharyngeal infection was 1.45-fold (95% CI: 1.19–1.77%), 2.75-fold (95% CI: 1.89–4.02%) and 2.64-fold (95% CI: 1.77–3.93%) higher among men than women. Current urogenital infection declined 0.97-fold (95% CI: 0.96–0.98%) yearly, but anorectal and oropharyngeal infection increased (1.02-fold; 95% CI: 1.01–1.04% and 1.02-fold; 95% CI: 1.00–1.04%), respectively. ConclusionsNeisseria gonorrhoeae epidemiology in Europe has distinct and contrasting epidemiologies for vaginal sex transmission in heterosexual sex networks vs anal and oral sex transmission in MSM sexual networks. Increased transmission may facilitate drug-resistant strain emergence. Europe is far from achieving the World Health Organization target of 90% incidence reduction by 2030.
Læs mere
3
Longer IV Ertapenem Course Beneficial for Recalcitrant HS
Medscape Infectious Diseases, 23.02.2024
Tilføjet 23.02.2024
2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning. MDedge News
Læs mere
4
Postinfectious Cough: Are Treatments Ever Warranted?
Medscape Infectious Diseases, 15.02.2024
Tilføjet 15.02.2024
Facing limited data and an absence of guidelines, clinicians debate what to do. Medscape Medical News
Læs mere
5
Rubella Screening in Pregnancy No Longer Recommended in Italy
Medscape Infectious Diseases, 24.01.2024
Tilføjet 24.01.2024
The elimination of the endemic transmission of rubella in Italy prompted a reconsideration of the country’s pregnancy guidelines. Medscape Medical News
Læs mere
6
Mask Rift Puts Health Workers in Jeopardy Again
Medscape Infectious Diseases, 14.12.2023
Tilføjet 14.12.2023
\'Guidelines that are incomplete, weak, and without scientific basis will greatly undermine CDC’s credibility,\' said a former OSHA director. KFF Health News
Læs mere
7
RECOMMENDATIONS AND REPORTS: CDC Guidelines for the Prevention and Treatment of Anthrax, 2023
Morbidity and Mortality Weekly Report (MMWR), 14.11.2023
Tilføjet 14.11.2023
This report describes updated guidelines and recommendations for prevention and treatment of anthrax.
Læs mere
8
Increasing proportions of extended-spectrum β-lactamase-producing isolates among Escherichia coli from urine and bloodstream infections: results from a nationwide surveillance network, Finland, 2008 to 2019
Heikki Ilmavirta, Jukka Ollgren, Kati Räisänen, Tuure Kinnunen, Antti J Hakanen, Jari Jalava and Outi Lyytikäinen
Eurosurveillance latest updates, 27.10.2023
Tilføjet 27.10.2023
BackgroundEscherichia coli is the leading cause of urinary tract infections (UTI) and bloodstream infections (BSI), and the emergence of antimicrobial resistance (AMR) in E. coli causes concern. AimTo investigate changes in the proportion of extended-spectrum β-lactamase (ESBL) producing isolates among E. coli isolated from urine and blood in Finland during 2008–2019. MethodsSusceptibility testing of 1,568,488 urine (90% female, 10% male) and 47,927 blood E. coli isolates (61% female, 39% male) from all Finnish clinical microbiology laboratories during 2008–2019 was performed according to guidelines from the Clinical and Laboratory Standard Institute during 2008–2010 and the European Committee on Antimicrobial Susceptibility Testing during 2011–2019. A binomial regression model with log link compared observed trends over time and by age group and sex. ResultsThe annual proportion of ESBL-producing E. coli isolates among E. coli from blood cultures increased from 2.4% (23/966) to 8.6% (190/2,197) among males (average annual increase 7.7%; 95% CI: 4.4–11.0%, p
Læs mere
9
AHA Updates CPR Guidelines on Cardiac Arrest After Poisoning
Medscape Infectious Diseases, 3.10.2023
Tilføjet 3.10.2023
The AHA update now includes the use of venoarterial extracorporeal membrane oxygenation for patients whose condition is refractory to other treatments. Medscape Medical News
Læs mere
10
New ESC Guidelines for Infective Endocarditis
Medscape Infectious Diseases, 27.08.2023
Tilføjet 27.08.2023
Endocarditis can present with many different clinical scenarios, so making the diagnosis can be challenging, says a co-chair of newly issued European guidelines for managing this disease. Medscape Medical News
Læs mere